Table 1. Patient background characteristics.

	Total patients (n = 41)	Alive (n = 34)	Dead (n = 7)	p value
Characteristics
Age, years	60 [28–70]	55.5 [21–68]	66 [65–73]	0.03
Sex, n (%)
Male	24 (59%)	20 (59%)	4 (57%)	1
Female	17 (41%)	14 (41%)	3 (43%)	1
MRSA career	20 (49%)	16 (47%)	4 (57%)	0.7
Surgical history	22 (54%)	18 (53%)	4 (57%)	1
Charlson Comorbidity Index	2 [1–4]	2 [1–4]	4 [2.5–6]	0.08
Source of BSI
Intravascular device	20 (49%)	18 (53%)	2 (29%)	0.22
Wound	7 (17%)	5 (15%)	2 (29%)
Urinary tract	4 (10%)	3 (9%)	1 (14%)
Lung	4 (10%)	4 (12%)	0
Skin/Soft tissue	3 (7%)	3 (9%)	0
Abdominal	2 (5%)	1 (3%)	1 (14%)
Meningitis	1 (3%)	0	1 (14%)
Detected location information
General ward	23 (56%)	18 (53%)	5 (71%)	0.46
ICU	7 (17%)	7 (21%)	0
Outpatient	11 (27%)	9 (26%)	2 (29%)
Clinical measure
Time to appropriate antimicrobial therapy (h)	30.5 [6.8–72.3]	25 [4.3–68]	70 [40.3–114]	0.15
ICU care	12 (29%)	11(32%)	1(14%)	0.65
Antimicrobial exposure within 30 days	19 (46%)	17 (50%)	2 (29%)	0.42

Demographics and characteristics of mortality after 30 days in patients with MRSA bacteremia at the University Hospital of the Kyoto Prefectural University of Medicine from October 2016 to May 2019.

Data presented as medians [IQRs] or n (%).

MRSA, methicillin-resistant Staphylococcus aureus; BSI, bloodstream infection; ICU, intensive care unit.